ClassID:

96376

C07H13/10 - CPC Classification

Classification description:

Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings

Recent Application in this class:
#1
20260042763
2026-02-12

PERIPHERALLY RESTRICTED GABA POSITIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME AND OTHER AILMENTS OF THE PERIPHERAL NERVOUS SYSTEM

#2
20240059725
2024-02-22

COUMARIN COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF

#3
20230416284
2023-12-28

MONO-TIN ORGANIC COMPOUND AND PREPARATION METHOD AND USE THEREOF

#4
20230340004
2023-10-26

PREPARATION METHOD FOR HIGH-PURITY GRANATIN A

#5
20230054304
2023-02-23

COMPOUND HAVING NEUROPROTECTIVE EFFECT, PREPARATION METHOD THEREFOR AND USE THEREOF

#6
20220289783
2022-09-15

Galactoside inhibitor of galectins

#7
20210401947
2021-12-30

CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN

#8
20210401946
2021-12-30

CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN

#9
20210338849
2021-11-04

COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

#10
20210054017
2021-02-25

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

#11
20200407391
2020-12-31

Galactoside inhibitor of galectins

#12
20200283464
2020-09-10

Ester of aminoglycan and uses thereof

#13
20200131215
2020-04-30

Sialic acid analogs

#14
20190381199
2019-12-19

Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders

#15
20190284201
2019-09-19

Bis-diox(ol)ane compounds

#16
20190209656
2019-07-11

Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein

#17
20190127409
2019-05-02

Sialic acid analogs

#18
20180251486
2018-09-06

Lincomycin biosynthetic intermediates, method for preparation, and use thereof

#19
20170349619
2017-12-07

Galactoside inhibitor of galectins

#20
20160297846
2016-10-13

Sialic acid analogs

#21
20160251318
2016-09-01

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#22
20160145213
2016-05-26

Heterocyclic compounds and methods of their use

#23
20150369797
2015-12-24

Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent

#24
20150038693
2015-02-05

Sialic acid analogs

#25
20140011988
2014-01-09

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#26
20130343995
2013-12-26

Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy

#27
20130315827
2013-11-28

Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders

#28
20130122094
2013-05-16

Sialic acid analogs

#29
20120184728
2012-07-19

Compound amycolose derivative, method for producing the same, and use of the same

#30
20110212904
2011-09-01

Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug

#31
20110196147
2011-08-11

INHIBITORS OF HISTONE DEACETYLASE

#32
20110060138
2011-03-10

Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders

#33
20100323999
2010-12-23

Therapeutic Molecules and Methods-1

#34
20100317838
2010-12-16

Cyclic carbonyl monomers functionalized with carbohydrates, polymers derived therefrom, and methods of preparation thereof

#35
20090076259
2009-03-19

Fluoridation Process

#36
20080207590
2008-08-28

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#37
20060280687
2006-12-14

Compounds for tissue imaging and methods of use thereof

#38
20060166929
2006-07-27

Sugar-chain asparagine derivatives and processes for the preparation thereof

#39
20060154977
2006-07-13

Therapeutic molecules and methods-1

#40
20060106102
2006-05-18

Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)

#41
20050215488
2005-09-29

Lincomycin derivatives possessing antibacterial activity

#42
20050192236
2005-09-01

Crystaline clindamycin free base

#43
20050187171
2005-08-25

Glycomimetic antagonists for both E-and P-selectins

#44
20050124563
2005-06-09

Triazole linked carbohydrates